Alvine Pharmaceuticals Obtains Series A Funding

  • Feed Type
  • Date
  • Company Name
    Alvine Pharmaceuticals
  • Mailing Address
    75 Shoreway Rd. San Carlos, CA 94070
  • Company Description
    Alvine Pharmaceuticals, Inc., is a biopharmaceutical company dedicated to developing and commercializing therapeutics for the treatment of Celiac sprue.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes from the investment were not disclosed.
  • M&A Terms
  • Venture Investor
    Abbott Biotech Ventures

Trending on Xconomy